Immunity against hepatitis C virus infection [2] (multiple letters)

Lancet

Volumn 360, Issue 9338, 2002, Pages 1019-1020

  Dore, Gregory J ^a   Freeman, Anthony J ^a,d   Kaldor, John M ^a   Post, Jeffrey J ^b   Harvey, Charles E ^d   Ffrench, Rosemary A ^d   Lloyd, Andrew R ^d   Mehta, Shruti H ^d   Cox, Andrea L ^d   Strathdee, Steffanie A ^d   Vlahov, David ^d   Thomas, David L ^c,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; VIRUS RNA;

AGE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); DEMOGRAPHY; DRUG USE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNITY; INCIDENCE; LETTER; MICROBIOLOGICAL PARAMETERS; NEEDLE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; RNA ANALYSIS; TIME; VIREMIA; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0037190586     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(02)11102-0     Document Type: Letter

References (5)

1. SH Mehta A Cox DR Hoover Protection against persistence of hepatitis C Lancet 359 2002 1478 1483
2. I Van Beek R Dwyer GJ Dore K Luo JM Kaldor Infection with HIV and hepatitis C among injecting drug users in a prevention setting: a retrospective cohort study BMJ 317 1998 433 437
3. F Lechner DK Wong PR Dunbar Analysis of successful immune responses in persons infected with hepatitis C virus J Exp Med 191 2000 1499 1512
4. P Farci A Shimoda A Coiana The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies Science 288 2000 339 344
5. M Thursz R Yallop R Goldin C Trepo HC Thomas Influence of MHC class II genotype on outcome of infection with hepatitis C virus: the HENCORE group- Hepatitis C European Network for Cooperative Research Lancet 354 1999 2119 2124